Herbert Irving Comprehensive Cancer Center
Investigator
Emerson Lim, MD
Email
el2342@cumc.columbia.edu

Dr. Lim received his B.S. in Biomedical Engineering from Johns Hopkins University. He earned his medical degree at The New York Univeristy School of Medicine where he was Alpha Omega Alpha. He completed his residency in Internal Medicine, and fellowship in Hematology and Medical Oncology at Columbia Univeristy Medical Center. During that time he was awared a Post-doctoral Fellowship Clinical Research Grant from the Susan G. Komen Foundation and completed a Masters degree in Biostatistics at the Mailman School of Public Health.

Dr. Lim cares for patients with genitourinary cancers, including prostate, bladder, kidney, and testicular cancers. His current research interest, for which he was awarded a pilot grant from the Irving Institute for Clinical and Translational Research, is in prostate cancer imaging to detect prostate cancer and to determine its aggressiveness. He also actively participates in multicenter cooperative group clinical trials and is involved in developing investigator-initiated studies to evaluate novel therapeutic agents discovered in the lab and novel combinations of agents for treatment of genitourinary malignancies.


Clinical Studies Managed By This Investigator:
Condition Study Title
Solid Tumors [ CLOSED ] A study for patients with solid tumors using study drug ASP5878
Cancer [ CLOSED ] A study for patients with advanced cancer using study drug BAY 1251152
Cancer [ CLOSED ] A study for patients with muscle invasive bladder cancer (MIBC) using study drugs MEDI4736 and AZD4547
Cancer [ CLOSED ] A study for patients with renal cell cancer using study drug sorafenib
Cancer [ CLOSED ] Phase I Assessment of AZD4635 as a Monotherapy and in Combination with Durvalumab in Patients with Advanced Solid Malignancies
Solid Tumors [ CLOSED ] My Pathway: Study Evaluating Drug in Patients with Advanced Solid Tumors with Mutations or Gene Expression Abnormalities
Prostate Cancer [ CLOSED ] Study of Drug in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients with Prostate Cancer
Kidney Cancer [ CLOSED ] Study of Drug in Patients with Renal Cell Carcinoma (RCC; Type of Kidney Cancer) after Nephrectomy (Removal of all or Part of Kidney)
Kidney Cancer [ CLOSED ] FRACTION: Study of Drug Combinations in Patients with Advanced Renal Cell Carcinoma
Cancer [ CLOSED ] Study of Drug in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors
Prostate Cancer [ CLOSED ] Diffuse Optical Tomography in Prostate Cancer Detection and Risk Stratification - A Pilot Study
Bladder Cancer [ CLOSED ] Study of Chemotherapy alone, Chemotherapy plus Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer
Solid Tumors [ CLOSED ] A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors
Prostate Cancer [ CLOSED ] Study of AZD4635 in Patients with Prostate Cancer